Compared to Estimates, ANI (ANIP) Q2 Earnings: A Look at Key Metrics
ANI Pharmaceuticals(ANIP) ZACKS·2024-08-06 15:00
ANI Pharmaceuticals (ANIP) reported $138.04 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 18.4%. EPS of $1.02 for the same period compares to $1.28 a year ago.The reported revenue represents a surprise of +8.16% over the Zacks Consensus Estimate of $127.62 million. With the consensus EPS estimate being $0.93, the EPS surprise was +9.68%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to W ...